$VKTX News and Market Events
Every $VKTX story Market Flux has tracked.
- Last 7 days
- 0 stories
- Previous 7 days
- 0 stories
- Latest story
- Related topics
- Healthcare, Corporate Actions
- Market Flux Event
Viking Therapeutics Starts Oral-Only Maintenance Dosing Trial of Obesity Drug VK2735 in 195 Patients
Viking Therapeutics (Nasdaq: VKTX) announced on October 6, 2026 the initiation of a new clinical trial evaluating oral maintenance dosing of its obesity drug VK2735, marking Part 2 of the…
- Most Active
Viking Therapeutics Raises $500M in Upsized Stock and Convertible Note Offering After Weight-Loss Drug Surge
Viking Therapeutics priced concurrent public offerings totaling roughly $500 million on September 24, 2026, capitalizing on a sharp rally tied to positive results from its VK2735…
- Most Active
Viking Therapeutics VK2735 Retains Up to 97% of Weight Loss With Reduced Dosing, Stock Surges 30% Plus
Viking Therapeutics reported positive topline results from a maintenance study of its dual GLP-1/GIP agonist VK2735, showing the drug held up to 97% of prior weight loss when patients…
- Unusual Volume
Viking Therapeutics Surges Up to 36% After VK2735 Maintains 90-97% of Weight Loss at Reduced Dosing Frequencies
Viking Therapeutics reported positive topline results from a maintenance study of VK2735, its dual GLP-1/GIP receptor agonist, showing that patients who had lost roughly 16% to 19% of body…
- Market Flux Event
Dozens of Healthcare and Biotech Companies Showcase Pipelines and Launch Plans at Morgan Stanley, Jefferies and H.C. Wainwright Conferences
September 14, 2026 saw a broad wave of healthcare and biotech presentations across three major investor conferences, with the Morgan Stanley 24th Annual Global Healthcare Conference drawing…